Bengaluru, January 03, 2026: Natural Capsules Limited (BSE: 524654 | NSE: NATCAPSUQ) on Friday informed stock exchanges that its material subsidiary, Natural Biogenex Private Limited, has decided not to proceed with the proposed rights issue.
The decision was taken at the board meeting of Natural Biogenex Private Limited held on January 03, 2026. The subsidiary has withdrawn the proposed allotment of shares under the rights issue due to non subscription by the major shareholder.
The update follows an earlier intimation made on September 30, 2025, when the company had informed the exchanges about the proposed rights issue at the subsidiary level. With the latest board decision, the rights issue will not be taken forward.
Key Details
| Particulars | Details |
|---|---|
| Subsidiary | Natural Biogenex Private Limited |
| Action | Rights issue not proceeded with |
| Board Meeting Date | January 03, 2026 |
| Reason | Non subscription by major shareholder |
| Parent Company | Natural Capsules Limited |
About the Company
Natural Capsules Limited is listed on the BSE and NSE and is engaged in the manufacture of empty hard gelatin capsules and allied products, catering to pharmaceutical and nutraceutical companies in India and overseas.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.